Hyperglycemia-induced alterations of gut microflora and therapeutic strategy in a critically ill model
Project/Area Number |
21390484
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Emergency medicine
|
Research Institution | Keio University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
AI Kimiaki 慶應義塾大学, 医学部, 助教 (30265847)
矢島 聡 慶應義塾大学, 医学部, 助教 (10348766)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥11,310,000 (Direct Cost: ¥8,700,000、Indirect Cost: ¥2,610,000)
Fiscal Year 2011: ¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2010: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2009: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
|
Keywords | 高血糖 / 敗血症 / 腸管関連リンパ組織 / 炎症性サイトカイン / 腸管壁防御機構 / 腸内細菌 / リンパ球サブセット / Th1 / Th2 / Th17 / regulatory T cell / 腸内細菌叢 / サイトカイン |
Research Abstract |
In this study, we examined if persistent hyperglycemia elicited alterations of gut barrier function in a critical ill model. Short-term hyperglycemia augmented gut mucosal permeability in an endotoxemic model, while long-term hyperglycemia for 24hr resulted in the up-regulation of inflammatory cytokines such as IL-1β and IL-6 in mesenteric lymph nodes, and of T lymphocyte subset such as helper T2 and regulatory T cells in gut. The present study shed light on the significant effects of clinically relevant level of persistent hyperglycemia on gut barrier function and immune system in critical ill.
|
Report
(4 results)
Research Products
(11 results)